May 13, 2019
President Trump on Thursday announced that his administration has reached a "historic" agreement with Gilead Sciences, under which the drugmaker will donate its HIV-prevention drug Truvada to millions of U.S. residents.
May 10, 2019
President Trump on Thursday called on Congress to propose and approve legislation to address so-called "surprise" medical bills and vowed to allow states to import lower-cost prescription drugs from other countries.
Sen. Elizabeth Warren (D-Mass.) this week unveiled a $100 billion proposal to combat the U.S. opioid epidemic that would emphasize employment and evidenced-based treatment for those struggling with substance use disorders, as well as provider training on treatment methods.
American Health Line rounds up the latest health care news in the states.
May 9, 2019
A federal judge on Monday ordered HHS to come up with a remedial measure that would address hospital payment cuts under Medicare's 340B drug discount program for 2018 and 2019, which the judge previously ruled were unlawful.
May 8, 2019
HHS on Wednesday released a final rule that will require drugmakers to disclose their products' list prices in consumer-directed television advertisements.
Startups throughout the health care industry are threatening to disrupt the traditional landscape, so to get an idea of which ones live up to the hype, Business Insider reporter Lydia Ramsey tried seven health startups and shared what she learned.
May 7, 2019
Forbes recently released its ranking of "America's Best Large Employers" and "America's Best Midsize Employers" for 2019, which included top employers among health care providers, insurers, biotech companies, and more.
Doctors have identified a type of dementia that might be more common than Alzheimer's disease, according to a report published last week in the journal Brain, and some experts are calling the discovery "the most important dementia finding in years."
May 6, 2019
The United States' total prescription drug costs are not expected to decrease if CMS finalizes a rule designed to prohibit drugmakers from paying rebates to pharmacy benefit managers, according to a Congressional Budget Office report released Thursday.
Advisory Board. All rights reserved.